Literature DB >> 12062054

C. elegans class B synthetic multivulva genes act in G(1) regulation.

Mike Boxem1, Sander van den Heuvel.   

Abstract

The single C. elegans member of the retinoblastoma gene family, lin-35 Rb, was originally identified as a synthetic Multivulva (synMuv) gene [1]. These genes form two redundant classes, A and B, that repress ectopic vulval cell fate induction. Recently, we demonstrated that lin-35 Rb also acts as a negative regulator of G(1) progression and likely is the major target of cyd-1 Cyclin D and cdk-4 CDK4/6. Here, we describe G(1) control functions for several other class B synMuv genes. We found that efl-1 E2F negatively regulates cell cycle entry, while dpl-1 DP appeared to act both as a positive and negative regulator. In addition, we identified a negative G(1) regulatory function for lin-9 ALY, as well as lin-15B and lin-36, which encode novel proteins. Inactivation of lin-35 Rb, efl-1, or lin-36 allowed S phase entry in the absence of cyd-1/cdk-4 and increased ectopic cell division when combined with cki-1 Cip/Kip RNAi. These data are consistent with lin-35 Rb, efl-1, and lin-36 acting in a common pathway or complex that negatively regulates G(1) progression. In contrast, lin-15B appeared to act in parallel to lin-35. Our results demonstrate the potential for genetic identification of novel G(1) regulators in C. elegans.

Entities:  

Mesh:

Year:  2002        PMID: 12062054     DOI: 10.1016/s0960-9822(02)00844-8

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  47 in total

1.  New genes that interact with lin-35 Rb to negatively regulate the let-60 ras pathway in Caenorhabditis elegans.

Authors:  Jeffrey H Thomas; Craig J Ceol; Hillel T Schwartz; H Robert Horvitz
Journal:  Genetics       Date:  2003-05       Impact factor: 4.562

2.  Identification of a Drosophila Myb-E2F2/RBF transcriptional repressor complex.

Authors:  Peter W Lewis; Eileen L Beall; Tracey C Fleischer; Daphne Georlette; Andrew J Link; Michael R Botchan
Journal:  Genes Dev       Date:  2004-11-15       Impact factor: 11.361

Review 3.  Cancer models in Caenorhabditis elegans.

Authors:  Natalia V Kirienko; Kumaran Mani; David S Fay
Journal:  Dev Dyn       Date:  2010-05       Impact factor: 3.780

Review 4.  The SynMuv genes of Caenorhabditis elegans in vulval development and beyond.

Authors:  David S Fay; John Yochem
Journal:  Dev Biol       Date:  2007-03-20       Impact factor: 3.582

Review 5.  DNA transposons and the evolution of eukaryotic genomes.

Authors:  Cédric Feschotte; Ellen J Pritham
Journal:  Annu Rev Genet       Date:  2007       Impact factor: 16.830

6.  mir-35 is involved in intestine cell G1/S transition and germ cell proliferation in C. elegans.

Authors:  Min Liu; Pengpeng Liu; Li Zhang; Qingchun Cai; Ge Gao; Wenxia Zhang; Zuoyan Zhu; Dong Liu; Qichang Fan
Journal:  Cell Res       Date:  2011-06-21       Impact factor: 25.617

7.  LIN-35/Rb causes starvation-induced germ cell apoptosis via CED-9/Bcl2 downregulation in Caenorhabditis elegans.

Authors:  L I Láscarez-Lagunas; C G Silva-García; T D Dinkova; R E Navarro
Journal:  Mol Cell Biol       Date:  2014-04-21       Impact factor: 4.272

8.  The identities of sym-2, sym-3 and sym-4, three genes that are synthetically lethal with mec-8 in Caenorhabditis elegans.

Authors:  John Yochem; Leslie R Bell; Robert K Herman
Journal:  Genetics       Date:  2004-11       Impact factor: 4.562

9.  Textpresso: an ontology-based information retrieval and extraction system for biological literature.

Authors:  Hans-Michael Müller; Eimear E Kenny; Paul W Sternberg
Journal:  PLoS Biol       Date:  2004-09-21       Impact factor: 8.029

10.  IRI-1, a LIN-15B homologue, interacts with inositol-1,4,5-triphosphate receptors and regulates gonadogenesis, defecation, and pharyngeal pumping in Caenorhabditis elegans.

Authors:  Denise S Walker; Sung Ly; Nicholas J D Gower; Howard A Baylis
Journal:  Mol Biol Cell       Date:  2004-05-07       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.